ETM, a Graco Company, has begun offering its Transverse Flux Motor (TFM) technology through a partnership model that allows OEMs to retain manufacturing control, protect margins and accelerate ...

Electric Torque Machines, or ETM, last week entered the robotics and advanced actuator market with its transverse flux motor technology. The company said it is offering its TFM technology through a ...

Energy Transition Minerals has landed $24.7 million in a strongly supported placement to progress the Kvanefjeld rare earth project in Greenland. Binding commitments to raise $24.7 million at 13c per ...

What is the current share price of Energy Transition Minerals Ltd (ETM)? Energy Transition Minerals Ltd's (ETM) current share price is $0.14. This constitutes a price movement of 28.95% when compared ...

Energy Transition Minerals, an ASX-listed rare earths tiddler that has tripled in size over the past year as US President Donald Trump seeks to annex Greenland, was asking investors for $20 million on ...

Energy Transition Minerals (ASX:ETM) has drawn fresh investor attention after appointing US firm Ballard Partners as public affairs advisors and Cohen & Company Capital Markets as exclusive US ...

Evacuations start in Libya where UNHCR staff identify vulnerable asylum seekers and refugees in need of international protection. Many of these individuals have been housed in detention centers and ...

ETM asks Greenland High Court to remove Denmark from case after recent legal wins Move clears path for substantive hearing on Kvanefjeld licence claim Company remains open to finding common ground ...

Qualys, Inc. (QLYS) recently reported its Q3 financial results, beating both revenue and earnings estimates. I previously analyzed QLYS in April, upgrading it with a Hold outlook due to improved ...

Energy Transition Minerals forms Advisory Board and adds two appointments The board will support the company’s engagement with Greenlandic and Danish stakeholders Further appointments to the board are ...

Camcevi ETM, a long-acting injectable, is FDA-approved for advanced prostate cancer, showing 97.9% efficacy in testosterone suppression in a phase 3 study. Common side effects include hot flushing and ...

Camcevi ETM contains 21mg of leuprolide and is administered every 3 months. The Food and Drug Administration (FDA) has approved Camcevi ETM ®, a long-acting formulation of leuprolide mesylate, for the ...